Hospital Universitari Germans Trias i Pujol -ko ikertzaileekin lankidetzan egindako argitalpenak (40)

2020

  1. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)

    Internal and Emergency Medicine

2019

  1. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)

    Internal and Emergency Medicine

  2. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Internal and Emergency Medicine

2018

  1. Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry

    Journal of the American Heart Association, Vol. 7, Núm. 17

  2. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Thrombosis Research, Vol. 164, pp. 69-74

  3. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691

2017

  1. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

    Chest, Vol. 151, Núm. 3, pp. 564-571

  2. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9

2016

  1. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer

    Journal of Thoracic Oncology, Vol. 11, Núm. 1, pp. 39-51

  2. Trends in the Management and Outcomes of Acute Pulmonary Embolism Analysis from the RIETE Registry

    Journal of the American College of Cardiology, Vol. 67, Núm. 2, pp. 162-170

  3. Type 2 diabetes is associated with a higher incidence of hospitalization for pulmonary embolism in Spain: Analysis of hospital discharge data during 2004–2013

    Respirology, Vol. 21, Núm. 7, pp. 1277-1284

2015

  1. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs

    American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15

  2. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 7, pp. 1274-1278

  3. Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism

    Medicine (United States), Vol. 94, Núm. 32

  4. Fondaparinux in the initial and long-term treatment of venous thromboembolism

    Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317

  5. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: A practical approach

    Clinical and Applied Thrombosis/Hemostasis, Vol. 21, Núm. 4, pp. 297-308

  6. Trend and seasonality in hospitalizations for pulmonary embolism: A time-series analysis

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 1, pp. 23-30

  7. Venous thromboembolism in patients immobilised at home

    European Respiratory Journal

2014

  1. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer

    Annals of Surgical Oncology, Vol. 21, Núm. 2, pp. 612-620

  2. Bleeding and venous thromboembolism arising in acutely ill hospitalized medical patients. Findings from the Spanish National Discharge Database

    European Journal of Internal Medicine, Vol. 25, Núm. 2, pp. 137-141